 |
2-(3-Diethylaminopropyl)-8,8-dipropyl-2-azaspiro[4,5] decane dimaleate |
|---|---|
| Trade Name | Atiprimod |
| Orphan Indication | Carcinoid tumors |
| USA Market Approval | USA |
| USA Designation Date | 2006-09-18 00:00:00 |
| Sponsor | Callisto Pharmaceuticals, Inc.;420 Lexington Avenue;New York, New York, 10170 |
